Modified risk tobacco product

[5] Swedish Match sought approval to remove warnings about mouth cancer, gum disease, and tooth loss from packaging of eight of its General Snus products.

The company also asked the US FDA to strike a statement reading "this product is not a safe alternative to cigarettes" as required by the Family Smoking Prevention and Tobacco Control Act.

The company asked the US FDA to replace the statement with language acknowledging the harmful nature of all tobacco products and the reduced risk profile of Swedish snus by comparison.

[5] In December 2016, the FDA initially rejected Swedish Match's application on the grounds that its snus were not actually safer than other smokeless tobacco products or cigarettes.

[7] iQOS was ultimately approved for sale in the United States using pre-market tobacco application method on April 30, 2019, which subjected it to marketing restrictions.